Kliqqo

Amlodipine besilate and nebivolol hydrochloride, the active ingredients in Kliqqo, are a calcium channel blocker and a beta blocker respectively, presented as an oral tablet for oral use. They lower blood pressure in adults with hypertension.

GNH USA supplies Kliqqo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kliqqo is an antihypertensive medication that acts on vascular tone and cardiac output to control high blood pressure.

Essential hypertension: reduces systolic and diastolic blood pressure. Secondary hypertension: assists in controlling pressure when caused by other conditions. Isolated systolic hypertension in the elderly: improves vascular compliance and lowers pressure.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Peripheral edema: swelling of ankles or feet due to fluid accumulation. - Dizziness or light‑headedness: related to blood‑pressure lowering. - Flushing: transient warmth and redness of the skin. - Fatigue: general feeling of tiredness. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Bradycardia: abnormally slow heart rate. - Heart block or atrioventricular conduction disturbances. - Angioedema: swelling of face, lips, tongue or throat. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Allergic reactions: rash, itching, or anaphylaxis.

Before initiating therapy, clinicians should consider the following precautions.

Monitor blood pressure: adjust dosage based on response. Assess renal function: dose may need modification in renal impairment. Evaluate for heart failure: avoid rapid dose escalation in decompensated states. Avoid concomitant strong CYP3A4 inhibitors: may increase nebivolol levels. Pregnancy and lactation: use only if benefits outweigh potential risks. Store at ambient temperature: keep in original container, protect from moisture.

Kliqqo may interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Concomitant use with other antihypertensives: risk of excessive hypotension. - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase nebivolol exposure. - Non‑dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem): additive cardiac depression.

Moderate Interactions (Monitor Closely): - Diuretics: may cause electrolyte shifts and augment blood‑pressure lowering. - NSAIDs: can attenuate antihypertensive effect. - Alcohol: may increase dizziness and hypotension.